Jennison Associates LLC Cabaletta Bio, Inc. Transaction History
Jennison Associates LLC
- $167 Billion
- Q2 2025
A detailed history of Jennison Associates LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 6,020,167 shares of CABA stock, worth $8.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,020,167
Previous 2,433,728
147.36%
Holding current value
$8.67 Million
Previous $3.38 Million
170.55%
% of portfolio
0.01%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CABA
# of Institutions
94Shares Held
77.1MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$13.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$12.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.78 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$7.2 Million0.77% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.8MShares$6.91 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $41.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...